Search Results - "Huguet, Jose María"

Endoscopic evaluation of immunotherapy-induced gastrointestinal toxicity by Iranzo, Isabel, Huguet, Jose María, Suárez, Patricia, Ferrer-Barceló, Luis, Iranzo, Vega, Sempere, Javier

“…Immunotherapy is any treatment aimed at boosting or enhancing the immune system. It includes a wide range of options, from vaccines to treatment for conditions…”
Get full text

Endoscopic recommendations for colorectal cancer screening and surveillance in patients with inflammatory bowel disease:Review of general recommendations by Huguet, Jose María, Suárez, Patricia, Ferrer-Barceló, Luis, Ruiz, Lucía, Monzó, Ana, Durá, Ana Belén, Sempere, Javier

“…Screening for colorectal cancer(CRC) in patients with inflammatory bowel disease(IBD) is recommended by all scientific societies. However, there are…”
Get full text

Metabolomic‐based noninvasive serum test to diagnose nonalcoholic steatohepatitis: Results from discovery and validation cohorts by Mayo, Rebeca, Crespo, Javier, Martínez‐Arranz, Ibon, Banales, Jesus M, Arias, Mayte, Mincholé, Itziar, Aller de la Fuente, Rocío, Jimenez‐Agüero, Raúl, Alonso, Cristina, de Luis, Daniel A., Vitek, Libor, Stritesky, Jan, Caballería, Joan, Romero‐Gómez, Manuel, Martín‐Duce, Antonio, Mugüerza Huguet, Jose Maria, Busteros‐Moraza, José Ignacio, Idowu, Michael O., Castro, Azucena, Martínez‐Chantar, M. Luz, Ortiz, Pablo, Bruha, Radan, Lu, Shelly C., Bedossa, Pierre, Noureddin, Mazen, Sanyal, Arun J., Mato, José M.

“…Nonalcoholic fatty liver disease (NAFLD) is the most common type of chronic liver disease worldwide and includes a broad spectrum of histologic phenotypes,…”
Get full text

Endoscopic progression of ulcerative proctitis to proximal disease. Can we identify predictors of progression? by Huguet, Jose María, Ferrer-Barceló, Luis, Suárez, Patrícia, Albert, Cecilia, Gonzalez, Lara, Castillo, Genesis, Boix, Carlos, García, Laura, Gallego, Juan, Sempere, Javier

“…Introduction: Ulcerative proctitis is a type of ulcerative colitis circumscribed to the rectum. Proximal progression rates of the disease have been reported as…”
Get full text

Short-term effectiveness of golimumab for ulcerative colitis: Observational multicenter study by Bosca-Watts, Marta Maia, Cortes, Xavier, Iborra, Marisa, Huguet, Jose Maria, Sempere, Laura, Garcia, Gloria, Gil, Rafa, Garcia, MariFe, Muñoz, Marga, Almela, Pedro, Maroto, Nuria, Paredes, Jose Maria

“…AIM To evaluate the real-world effectiveness of golimumab in ulcerative colitis(UC) and to identify predictors of response.METHODS We conducted an…”
Get full text

Real-world data on the infliximab biosimilar CT-P13 (Remsima ® ) in inflammatory bowel disease by Huguet, Jose María, Cortés, Xavier, Bosca-Watts, Marta Maia, Aguas, Marian, Maroto, Nuria, Martí, Lidia, Amorós, Cirilo, Paredes, Jose María

“…In recent years, biological therapies have revolutionized the management of inflammatory bowel disease (IBD); however, they are expensive. The development of…”
Get full text

Ferric Carboxymaltose Improves the Quality of Life of Patients with Inflammatory Bowel Disease and Iron Deficiency without Anaemia by Huguet, Jose María, Cortés, Xavier, Boscá-Watts, Marta Maia, Muñoz, Margarita, Maroto, Nuria, Iborra, Marisa, Hinojosa, Esther, Capilla, María, Asencio, Carmina, Amoros, Cirilo, Paredes, Jose María

“…Background: Iron deficiency (ID) without anaemia is a common comorbidity associated with inflammatory bowel disease (IBD) that has a negative impact on…”
Get full text

Screening for colorectal cancer in patients with inflammatory bowel disease. Should we already perform chromoendoscopy in all our patients? by Huguet, Jose María, Suárez, Patrícia, Ferrer-Barceló, Luis, Iranzo, Isabel, Sempere, Javier

“…Patients with inflammatory bowel disease (commonly known as IBD) have a greater risk of colorectal cancer than the general population. Therefore, they are…”
Get full text

Colorectal cancer screening and surveillance in patients with inflammatory bowel disease in 2021 by Huguet, Jose Maria, Ferrer-Barceló, Luis, Suárez, Patrícia, Sanchez, Eva, Prieto, Jose David, Garcia, Victor, Sempere, Javier

“…The detection of dysplasia in patients with inflammatory bowel disease (IBD) continues to be important given the increased risk of colorectal cancer in this…”
Get full text

Short and long‐term effectiveness and safety of vedolizumab in inflammatory bowel disease: results from the ENEIDA registry by Chaparro, María, Ricart, Elena, Iborra, Marisa, Mesonero, Francisco, García‐Sánchez, Valle, Luisa De Castro, M., Martin‐Cardona, Albert, Aldeguer, Xavier, Mínguez, Miguel, Andreu, Montserrat, González‐Muñoza, Carlos, Bermejo, Fernando, Huguet, Jose Maria, Mañosa, Míriam, Carbajo, Ana Y., Lorente, Rufo, García‐López, Santiago, Piqueras, Marta, Hinojosa, Esther, Arajol, Clàudia, Sicilia, Beatriz, Conesa, Ana Macho, Sainz, Empar, Almela, Pedro, Llaó, Jordina, Roncero, Oscar, Domselaar, Manuel Van, Madrigal, Rosa, Alcaín, Guillermo, Bernardo, D., Ricart, E., Ricart, E., Alfaro, I., Nos, P., Mesonero, F., Vera, M., Vera, M., Calvo Moya, M., Calvo Moya, M., Riestra, S., de Francisco, R., García‐Sánchez, V., Iglesias Flores, E., De Castro, L., Pineda, J.R., Pineda, J.R., Martin‐Cardona, A., Esteve, M., Busquet, D., Mínguez, M., Mínguez, M., Navarro, P., Barreiro de‐Acosta, M., Barreiro de‐Acosta, M., Bastón, I., Rivero, M., García, M.J., Muñoz, F., Piñero, C., Andreu, M., Márquez Mosquera, L., Navarro‐Llavat, M., Garcia‐Planella, E., Garcia‐Planella, E., González‐Muñoza, C., García‐Sepulcre, M.F., Jiménez, N., Bermejo, F., Algaba, A., Huguet, J.M., Ruiz, L., Cabriada, J.L., Gutiérrez, A., Sempere Robles, L., Mañosa, M., Clos‐Parals, A., Clos‐Parals, A., Villoria, A., Calvet, X., Verdejo, C., Llorente Barrio, M., Mena, R., Maroto, N., Arias García, L., Fernández‐Salazar, L., Sesé, E., Sesé, E., Muñoz, M., Muñoz, M., Giménez Roca, A., Domínguez, M., Domínguez, M., Alba, C., Blázquez Gómez, I., Manceñido Marcos, N., Manceñido Marcos, N., Arias Rodríguez, L., Angueira, T., Angueira, T., García, A.

“…Summary Background Effectiveness of vedolizumab in real world clinical practice is unknown. Aim To evaluate the short and long‐term effectiveness of…”
Get full text

Effectiveness and safety of a third‐line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study) by García, María José, Riestra, Sabino, Amiot, Aurelien, Julsgaard, Mette, García de la Filia, Irene, Calafat, Margalida, Aguas, Mariam, Peña, Luisa, Roig, Cristina, Caballol, Berta, Casanova, María José, Farkas, Klaudia, Boysen, Trine, Bujanda, Luis, Cuarán, Camila, Dobru, Daniela, Fousekis, Fotios, Gargallo‐Puyuelo, Carla Jerusalén, Savarino, Edoardo, Calvet, Xavier, Huguet, José María, Kupcinskas, Limas, López‐Cardona, Julia, Raine, Tim, Oostrom, Joep, Gisbert, Javier P., Chaparro, María

“…Summary Background The advent of new therapeutic agents and the improvement of supporting care might change the management of acute severe ulcerative colitis…”
Get full text

Evaluation of changes in intestinal microbiota in Crohn’s disease patients after anti-TNF alpha treatment by Sanchis-Artero, Laura, Martínez-Blanch, Juan Francisco, Manresa-Vera, Sergio, Cortés-Castell, Ernesto, Valls-Gandia, Marina, Iborra, Marisa, Paredes-Arquiola, Jose Maria, Boscá-Watts, Maia, Huguet, Jose Maria, Gil-Borrás, Rafael, Rodríguez-Morales, Josefa, Cortés-Rizo, Xavier

“…Intestinal dysbiosis is key in the onset and development of Crohn’s disease (CD). We evaluated the microbiota changes in CD patients before and after a…”
Get full text

Zollinger-Ellison syndrome by Alventosa-Mateu, Carlos, Ferrer-Barceló, Luis, Huguet-Malavés, Jose María, Ferrer-Arranz, Luis, Monzó-Gallego, Ana, Medina-Chuliá, Enrique

Get full text

Information resources used by patients with inflammatory bowel disease: Satisfaction, expectations and information gaps by Catalán-Serra, Ignacio, Huguet-Malavés, Jose María, Mínguez, Miguel, Torrella, Emilio, Paredes, Jose María, Vázquez, Narciso, Ramírez, Jose Joaquín, Calvo, Félix, Nos, Pilar, Gutiérrez, Ana, Palau, Antonio, Cortés, Javier, Ramón-Monllor, Pilar, Hinojosa, Joaquín

“…Information received by IBD patients about their disease is of particular importance. The objective of the study was to determine the information resources…”
Get more information

Subcutaneous Infliximab Cutoff Points in Patients With Inflammatory Bowel Disease: Data From the ENEIDA Registry by Iborra, Marisa, Caballol, Berta, Garrido, Alejandro, Huguet, José María, Mesonero, Francisco, Ponferrada, Ángel, Arias García, Lara, Boscá Watts, Marta Maia, Fernández Prada, Samuel J, Brunet Mas, Eduard, Gutiérrez Casbas, Ana, Cerrillo, Elena, Ordás, Ingrid, Ruiz, Lucía, García de la Filia, Irene, Escobar Ortiz, Jaime, Sicilia, Beatriz, Ricart, Elena, Domènech, Eugeni, Nos, Pilar

“…Abstract Background and Aims Switching from intravenous infliximab (IV-IFX) to subcutaneous biosimilar infliximab (SC-IFX) has been shown to safely maintain…”
Get full text

Splanchnic Vein Thrombosis in Inflammatory Bowel Disease: An Observational Study from the ENEIDA Registry and Systematic Review by Puig, Maria, Masnou, Helena, Mesonero, Francisco, Menchén, Luís, Bujanda, Luís, Castro, Jesús, González-Partida, Irene, Vicente, Raquel, González-Muñoza, Carlos, Iborra, Marisa, Sierra, Mónica, Huguet, José María, García, María José, De Francisco, Ruth, García-Alonso, Francisco Javier, Mañosa, Míriam, Domènech, Eugeni, On Behalf Of Eneida-Geteccu Registry

“…Thromboembolic events are frequent among patients with inflammatory bowel disease (IBD). However, there is little information on the prevalence, features and…”
Get full text

Rapidity of clinical response to adalimumab and improvement of quality of life in luminal Crohn's disease: RAPIDA study by Marín-Jiménez, Ignacio, Acosta, Manuel Barreiro-de, Esteve, María, Castro-Laria, Luisa, García-López, Santiago, Ceballos, Daniel, Echarri, Ana, Martín-Arranz, María Dolores, Busquets, David, Llaó, Jordina, Navarro-Llavat, Mercè, Huguet, José María, Argüelles-Arias, Federico, Vicente, Raquel, Boudet, José Miguel, Díaz, Gema, Sánchez-Migallón, Ana M, Casellas, Francesc

“…No studies evaluating the rapidity of response to biological therapies are available for Crohn's disease (CD). The aim of this study was to evaluate rapidity…”
Get more information

Diagnostic-therapeutic management of bile duct cancer by Huguet, José María, Lobo, Miriam, Labrador, José Mir, Boix, Carlos, Albert, Cecilia, Ferrer-Barceló, Luis, Durá, Ana B, Suárez, Patricia, Iranzo, Isabel, Gil-Raga, Mireia, de Burgos, Celia Baez, Sempere, Javier

“…Biliary tract cancer, or cholangiocarcinoma, comprises a heterogeneous group of malignant tumors that can emerge at any part of the biliary tree. This group is…”
Get full text

Impact of BMGIM Music Therapy on Emotional State in Patients with Inflammatory Bowel Disease: A Randomized Controlled Trial by March-Luján, Vicente Alejandro, Prado-Gascó, Vicente, Huguet, José María, Cortés, Xavier, Arquiola, José María Paredes, Capilla-Igual, María, Josefa-Rodríguez-Morales, María, Monzó-Gallego, Ana, Armero, José Luis Platero, Ortí, José Enrique de la Rubia

“…Patients with inflammatory bowel disease (IBD) have a high prevalence of emotional disturbances which worsen the symptoms of the disease. As a therapeutic…”
Get full text

Septic thrombosis of internal jugular vein: a rare cause of uncontrollable hiccups by Sánchez-Gollarte, Ana, Mugüerza-Huguet, Jose María, Díez-Alonso, Manuel Mariano, Ovejero-Merino, Enrique, Mendoza-Moreno, Fernando, Hernández-Juara, Pilar, López-Ramos, María Esther, Noguerales-Fraguas, Fernando

“…Abstract Septic thrombosis of the internal jugular vein is a possible complication related to central venous catheters. The enlargement of the diameter of the…”
Get full text